Lovell’s Research Team Developing Safer Forms of Injectable Medicine

Updated June 21, 2016 This content is archived.

A team led by Jonathan F. Lovell, PhD, assistant professor of biomedical engineering, is developing a promising new drug-making technique designed to reduce serious allergic reactions and other side effects from anti-cancer medicine, testosterone and other drugs that are administered with a needle.

“For the drugs we looked at, this is as close as anyone has gotten to introducing pure, injectable medicine into the body,” Lovell said. “Essentially, it’s a new way to package drugs.”